| Product Code: ETC7373966 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Lumasiran Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Lumasiran Market - Industry Life Cycle |
3.4 Grenada Lumasiran Market - Porter's Five Forces |
3.5 Grenada Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Grenada Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Grenada Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Grenada Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Grenada Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Grenada Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Grenada Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of primary hyperoxaluria type 1 (PH1) which grenada lumasiran is indicated for |
4.2.2 Growing awareness about the benefits of RNAi therapeutics in treating rare diseases |
4.2.3 Favorable regulatory environment supporting the development and approval of orphan drugs |
4.3 Market Restraints |
4.3.1 High cost associated with grenada lumasiran treatment may limit access for patients |
4.3.2 Competition from existing treatments for PH1 |
4.3.3 Potential challenges in scaling up production to meet increasing demand |
5 Grenada Lumasiran Market Trends |
6 Grenada Lumasiran Market, By Types |
6.1 Grenada Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Grenada Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Grenada Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Grenada Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Grenada Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Grenada Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Grenada Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Grenada Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Grenada Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Grenada Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Grenada Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Grenada Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Grenada Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Grenada Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Grenada Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Grenada Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Grenada Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Grenada Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Grenada Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Grenada Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Grenada Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Grenada Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Grenada Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Grenada Lumasiran Market Import-Export Trade Statistics |
7.1 Grenada Lumasiran Market Export to Major Countries |
7.2 Grenada Lumasiran Market Imports from Major Countries |
8 Grenada Lumasiran Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for grenada lumasiran |
8.2 Physician adoption rate of grenada lumasiran in treating PH1 patients |
8.3 Number of publications and presentations highlighting the efficacy and safety of grenada lumasiran |
8.4 Time taken for regulatory approvals in key markets |
8.5 Patient adherence and compliance rates with grenada lumasiran therapy |
9 Grenada Lumasiran Market - Opportunity Assessment |
9.1 Grenada Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Grenada Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Grenada Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Grenada Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Grenada Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Grenada Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Grenada Lumasiran Market - Competitive Landscape |
10.1 Grenada Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Grenada Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here